Sanofi Pasteur MET43

Mar 3, 2021

Started: 7/2016 A Phase III, modified double-blind, randomized, parallel-group, active-controlled, multi-center study to evaluate immune lot consistency of xxx conjugate vaccine, evaluate the immune non-inferiority versus Menactra®, and describe the safety and additional immunogenicity of these study vaccines in adolescents and adults aged 10 to 55 years in the United States.

Indication: Meningitis

Principal Investigators: Paul Bernhardson, Luke Anschutz

 

This study is no longer active

Current Studies